Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,085
archived clinical trials in
Cervical Cancer

Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
A Phase I Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
Status: Enrolling
Updated:  7/15/2009
Yale University School of Medicine
mi
from
New Haven, CT
Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
A Phase I Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
Status: Enrolling
Updated: 7/15/2009
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
A Phase II Trial of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  2/3/2011
Emory University
mi
from
Atlanta, GA
Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
A Phase II Trial of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 2/3/2011
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients.
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients With Sentinel Lymph Nodes Determined to be Negative for Metastatic Disease.
Status: Enrolling
Updated:  2/9/2011
Women and Infants Hospital of Rhode Island
mi
from
Providence, RI
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients.
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients With Sentinel Lymph Nodes Determined to be Negative for Metastatic Disease.
Status: Enrolling
Updated: 2/9/2011
Women and Infants Hospital of Rhode Island
mi
from
Providence, RI
Click here to add this to my saved trials
Pelvic Floor Disorders in Survivors of Gynecologic Malignancies
The Prevalence and Predictive Factors of Pelvic Floor Disorders in Gynecologic Malignancy Survivors
Status: Enrolling
Updated:  6/8/2011
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Pelvic Floor Disorders in Survivors of Gynecologic Malignancies
The Prevalence and Predictive Factors of Pelvic Floor Disorders in Gynecologic Malignancy Survivors
Status: Enrolling
Updated: 6/8/2011
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Alternate Dosing Schedules Study for HPV Vaccine
Alternate Dosing Schedules Study for HPV Vaccine
Status: Enrolling
Updated:  6/28/2011
Chapel Hill Pediatrics
mi
from
Chapel Hill, NC
Alternate Dosing Schedules Study for HPV Vaccine
Alternate Dosing Schedules Study for HPV Vaccine
Status: Enrolling
Updated: 6/28/2011
Chapel Hill Pediatrics
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Alternate Dosing Schedules Study for HPV Vaccine
Alternate Dosing Schedules Study for HPV Vaccine
Status: Enrolling
Updated:  6/28/2011
Duke Children's Primary Care
mi
from
Durham, NC
Alternate Dosing Schedules Study for HPV Vaccine
Alternate Dosing Schedules Study for HPV Vaccine
Status: Enrolling
Updated: 6/28/2011
Duke Children's Primary Care
mi
from
Durham, NC
Click here to add this to my saved trials
Alternate Dosing Schedules Study for HPV Vaccine
Alternate Dosing Schedules Study for HPV Vaccine
Status: Enrolling
Updated:  6/28/2011
Durham Pediatrics
mi
from
Durham, NC
Alternate Dosing Schedules Study for HPV Vaccine
Alternate Dosing Schedules Study for HPV Vaccine
Status: Enrolling
Updated: 6/28/2011
Durham Pediatrics
mi
from
Durham, NC
Click here to add this to my saved trials
Letrozole as a Treatment of Endometrial Cancer
Predicting Aromatase Inhibitor Responsiveness in Endometrial Carcinoma
Status: Enrolling
Updated:  8/4/2011
University of California-Davis
mi
from
Sacramento, CA
Letrozole as a Treatment of Endometrial Cancer
Predicting Aromatase Inhibitor Responsiveness in Endometrial Carcinoma
Status: Enrolling
Updated: 8/4/2011
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Letrozole as a Treatment of Endometrial Cancer
Predicting Aromatase Inhibitor Responsiveness in Endometrial Carcinoma
Status: Enrolling
Updated:  8/4/2011
University of California-Davis
mi
from
Sacramento, CA
Letrozole as a Treatment of Endometrial Cancer
Predicting Aromatase Inhibitor Responsiveness in Endometrial Carcinoma
Status: Enrolling
Updated: 8/4/2011
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
Surgical Cytoreduction Followed by Intraoperative Intrathoracic Hyperthermic Chemotherapy Perfusion for the Management of Disseminated Pleural Malignancies
Status: Enrolling
Updated:  9/2/2011
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
Surgical Cytoreduction Followed by Intraoperative Intrathoracic Hyperthermic Chemotherapy Perfusion for the Management of Disseminated Pleural Malignancies
Status: Enrolling
Updated: 9/2/2011
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs)
A Randomized Trial of Buffered vs Nonbuffered Lidocaine With Epinephrine for Cervical Loop Excision
Status: Enrolling
Updated:  10/6/2011
Barnes-Jewish Hosptial/Siteman Cancer Center
mi
from
Saint Louis, MO
Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs)
A Randomized Trial of Buffered vs Nonbuffered Lidocaine With Epinephrine for Cervical Loop Excision
Status: Enrolling
Updated: 10/6/2011
Barnes-Jewish Hosptial/Siteman Cancer Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Photoacoustic Endoscopy in Endometrial Cancer
A Pilot Study of Photoacoustic Endoscopy in Endometrial Cancer
Status: Enrolling
Updated:  12/22/2011
Washington University School of Medicine
mi
from
Saint Louis, MO
Photoacoustic Endoscopy in Endometrial Cancer
A Pilot Study of Photoacoustic Endoscopy in Endometrial Cancer
Status: Enrolling
Updated: 12/22/2011
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids
Magnetic Resonance-Guided Focused Ultrasound to Treat Uterine Fibroids: A Pilot Randomized, Placebo-Controlled Trial
Status: Enrolling
Updated:  2/2/2012
University of California, San Francisco
mi
from
San Francisco, CA
Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids
Magnetic Resonance-Guided Focused Ultrasound to Treat Uterine Fibroids: A Pilot Randomized, Placebo-Controlled Trial
Status: Enrolling
Updated: 2/2/2012
University of California, San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
An Intervention Study To Improve HPV Immunization in Haitian and African American Girls
A Randomized Clinical Trial To Improve HPV Immunization in Haitian and African American Girls
Status: Enrolling
Updated:  2/21/2012
Boston Med Center
mi
from
Boston, MA
An Intervention Study To Improve HPV Immunization in Haitian and African American Girls
A Randomized Clinical Trial To Improve HPV Immunization in Haitian and African American Girls
Status: Enrolling
Updated: 2/21/2012
Boston Med Center
mi
from
Boston, MA
Click here to add this to my saved trials
Psychosocial Benefits of Exercise in Endometrial Cancer Survivors
Psychosocial Benefits of Exercise in Endometrial Cancer Survivors
Status: Enrolling
Updated:  2/24/2012
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Psychosocial Benefits of Exercise in Endometrial Cancer Survivors
Psychosocial Benefits of Exercise in Endometrial Cancer Survivors
Status: Enrolling
Updated: 2/24/2012
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids
A Phase 2, Three-arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Confirmed by Ultrasound
Status: Enrolling
Updated:  4/23/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids
A Phase 2, Three-arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Confirmed by Ultrasound
Status: Enrolling
Updated: 4/23/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids
A Phase 2, Three-arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Confirmed by Ultrasound
Status: Enrolling
Updated:  4/23/2012
Clinical Research Facility
mi
from
Dallas, TX
Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids
A Phase 2, Three-arm, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Confirmed by Ultrasound
Status: Enrolling
Updated: 4/23/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Extension of Study ZPV-200
A Phase 2, Multi-Center, Five-Arm, Parallel Design, Randomized, Single-Blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Confirmed by Ultrasound
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Extension of Study ZPV-200
A Phase 2, Multi-Center, Five-Arm, Parallel Design, Randomized, Single-Blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Confirmed by Ultrasound
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Extension of Study ZPV-200
A Phase 2, Multi-Center, Five-Arm, Parallel Design, Randomized, Single-Blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Confirmed by Ultrasound
Status: Enrolling
Updated:  6/28/2012
Clinical Research Facility
mi
from
Dallas, TX
Extension of Study ZPV-200
A Phase 2, Multi-Center, Five-Arm, Parallel Design, Randomized, Single-Blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Confirmed by Ultrasound
Status: Enrolling
Updated: 6/28/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated:  8/15/2012
Arizona Cancer Center
mi
from
Tucson, AZ
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated: 8/15/2012
Arizona Cancer Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated:  8/15/2012
USC Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated: 8/15/2012
USC Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated:  8/15/2012
Cedar Sinai-Samuel Oschin Comprehensive Cancer Institute
mi
from
Los Angeles, CA
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated: 8/15/2012
Cedar Sinai-Samuel Oschin Comprehensive Cancer Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated:  8/15/2012
Massachusetts General Hospital
mi
from
Boston, MA
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated: 8/15/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated:  8/15/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated: 8/15/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated:  8/15/2012
Oncology Consultants
mi
from
Houston, TX
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated: 8/15/2012
Oncology Consultants
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated:  8/15/2012
Cancer Therapy and Research Center
mi
from
San Antonio, TX
Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Phase 1 Study of Anti-HB-EGF Monoclonal Antibody KHK2866 as Monotherapy in Subjects With Advanced Solid Tumors and in Combination With Chemotherapy in Ovarian Cancer
Status: Enrolling
Updated: 8/15/2012
Cancer Therapy and Research Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
St. Joseph's Hospital & Medical Center St Jospeh's
mi
from
Phoenix, AZ
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
St. Joseph's Hospital & Medical Center St Jospeh's
mi
from
Phoenix, AZ
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Highlands Oncology Group Dept of Highlands Oncology Grp
mi
from
Fayetteville, AR
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Highlands Oncology Group Dept of Highlands Oncology Grp
mi
from
Fayetteville, AR
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
City of Hope National Medical Center City of Hope national Med Ctr
mi
from
Duarte, CA
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
City of Hope National Medical Center City of Hope national Med Ctr
mi
from
Duarte, CA
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
H. Lee Moffitt Cancer Center/University of South Florida Moffitt 3
mi
from
Tampa, FL
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
H. Lee Moffitt Cancer Center/University of South Florida Moffitt 3
mi
from
Tampa, FL
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Holy Cross Hospital Holly Cross
mi
from
Silver Spring, MD
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Holy Cross Hospital Holly Cross
mi
from
Silver Spring, MD
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Henry Ford Hospital Henry Ford
mi
from
Detroit, MI
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Henry Ford Hospital Henry Ford
mi
from
Detroit, MI
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Washington University School Of Medicine-Siteman Cancer Ctr Wash U
mi
from
St. Louis, MO
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Washington University School Of Medicine-Siteman Cancer Ctr Wash U
mi
from
St. Louis, MO
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Morristown Memorial Hospital MMH
mi
from
Morristown, NJ
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Morristown Memorial Hospital MMH
mi
from
Morristown, NJ
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Carolinas HealthCare Systems Blumenthal Cancer Center
mi
from
Charlotte, NC
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Carolinas HealthCare Systems Blumenthal Cancer Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Cancer Centers of North Carolina Cancer Centers of NC-Raleigh
mi
from
Raleigh, NC
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Cancer Centers of North Carolina Cancer Centers of NC-Raleigh
mi
from
Raleigh, NC
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
University of Oklahoma Health Sciences Center OU Health
mi
from
Oklahoma City, OK
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
University of Oklahoma Health Sciences Center OU Health
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Oregon Health & Science University (OHSU)
mi
from
Portland, OR
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Oregon Health & Science University (OHSU)
mi
from
Portland, OR
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Northwest Cancer Specialists Vancouver Location
mi
from
Portland, OR
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Northwest Cancer Specialists Vancouver Location
mi
from
Portland, OR
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Geisinger Health System GHS
mi
from
Danville, PA
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Geisinger Health System GHS
mi
from
Danville, PA
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Sarah Cannon Research Institute SCRI (2)
mi
from
Nashville, TN
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Sarah Cannon Research Institute SCRI (2)
mi
from
Nashville, TN
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Texas Oncology, P.A. Austin
mi
from
Bedford, TX
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Texas Oncology, P.A. Austin
mi
from
Bedford, TX
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Texas Oncology, P.A. Tex Onc (3)
mi
from
Bedford, TX
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Texas Oncology, P.A. Tex Onc (3)
mi
from
Bedford, TX
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
University of Texas Southwestern Medical Center Obstetrics and Gynecology
mi
from
Dallas, TX
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
University of Texas Southwestern Medical Center Obstetrics and Gynecology
mi
from
Dallas, TX
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
US Oncology Central Monitoring
mi
from
Dallas, TX
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
US Oncology Central Monitoring
mi
from
Dallas, TX
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
South Texas Oncology and Hematology, PA South Tex Onc
mi
from
San Antonio, TX
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
South Texas Oncology and Hematology, PA South Tex Onc
mi
from
San Antonio, TX
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Pacific Gynecology Specialists PGS
mi
from
Seattle, WA
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Pacific Gynecology Specialists PGS
mi
from
Seattle, WA
Click here to add this to my saved trials
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated:  9/30/2012
Cancer Care Northwest CC Northwest- Spokane South(3)
mi
from
Spokane, WA
BKM120 as Second-line Therapy for Advanced Endometrial Cancer
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients With Advanced Endometrial Carcinoma
Status: Enrolling
Updated: 9/30/2012
Cancer Care Northwest CC Northwest- Spokane South(3)
mi
from
Spokane, WA
Click here to add this to my saved trials
The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery
The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery
Status: Enrolling
Updated:  11/6/2012
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery
The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery
Status: Enrolling
Updated: 11/6/2012
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening
Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening
Status: Enrolling
Updated:  1/23/2013
OHSU Knight Cancer Institute
mi
from
Portland, OR
CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening
Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening
Status: Enrolling
Updated: 1/23/2013
OHSU Knight Cancer Institute
mi
from
Portland, OR
Click here to add this to my saved trials